- Connective licenses rights to Genentech's gamma interferon
- Roche acquires Syntex for $5.3 billion
- Xoma to help develop Genentech's anti-CD11a monoclonal
- Abgenix, Genentech form research collaboration
- Genentech accesses Incyte's LifeSeq database
- Centocor gets Retavase from Roche for $335mm
- Genentech, Inspire sign respiratory drug alliance
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
All fields are required.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.